Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report / 대한마취과학회지
Korean Journal of Anesthesiology
;
: 317-321, 2014.
Article
in English
| WPRIM
| ID: wpr-20456
ABSTRACT
Percutaneous trans-catheter aortic valve implantation (TAVI) is recommended for inoperable patients with severe aortic stenosis at high risk for conventional aortic valve replacement. Originally, TAVI was mostly performed under general anesthesia. Here we describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine. Dexmedetomidine provides sedation, analgesia with minimal respiratory depression. Although MAC during transfemoral TAVI has limitations, such as unexpected patient movement and difficulty in intra-procedural use of transesophageal echocardiography, MAC with dexmedetomidine is feasible with close monitoring, fluoroscopic guidance and the participation of experienced anesthesiologists.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Aortic Valve
/
Aortic Valve Stenosis
/
Respiratory Insufficiency
/
Echocardiography, Transesophageal
/
Heart Valve Prosthesis Implantation
/
Dexmedetomidine
/
Analgesia
/
Hypnotics and Sedatives
/
Anesthesia
/
Anesthesia, General
Limits:
Humans
Language:
English
Journal:
Korean Journal of Anesthesiology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS